Free Trial
NASDAQ:ZIMV

ZimVie (ZIMV) Stock Price, News & Analysis

ZimVie logo
$14.04
+0.27 (+1.96%)
(As of 11/1/2024 ET)

About ZimVie Stock (NASDAQ:ZIMV)

Key Stats

Today's Range
$13.80
$14.17
50-Day Range
$13.69
$17.99
52-Week Range
$6.52
$22.40
Volume
154,220 shs
Average Volume
158,492 shs
Market Capitalization
$387.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.33
Consensus Rating
Hold

Company Overview

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

ZimVie Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
49th Percentile Overall Score

ZIMV MarketRank™: 

ZimVie scored higher than 49% of companies evaluated by MarketBeat, and ranked 608th out of 975 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ZimVie has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    ZimVie has received no research coverage in the past 90 days.

  • Read more about ZimVie's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ZimVie is -1.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ZimVie is -1.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    ZimVie has a P/B Ratio of 0.95. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about ZimVie's valuation and earnings.
  • Percentage of Shares Shorted

    1.62% of the float of ZimVie has been sold short.
  • Short Interest Ratio / Days to Cover

    ZimVie has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ZimVie has recently increased by 1.25%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    ZimVie does not currently pay a dividend.

  • Dividend Growth

    ZimVie does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.62% of the float of ZimVie has been sold short.
  • Short Interest Ratio / Days to Cover

    ZimVie has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ZimVie has recently increased by 1.25%, indicating that investor sentiment is decreasing.
  • News Sentiment

    ZimVie has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for ZimVie this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, ZimVie insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $9,297,750.00 in company stock.

  • Percentage Held by Insiders

    Only 3.01% of the stock of ZimVie is held by insiders.

  • Percentage Held by Institutions

    95.63% of the stock of ZimVie is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about ZimVie's insider trading history.
Receive ZIMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZimVie and its competitors with MarketBeat's FREE daily newsletter.

ZIMV Stock News Headlines

ZimVie Reports Third Quarter 2024 Financial Results
ZimVie Inc. (ZIMV) Q3 2024 Earnings Call Transcript
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
ZimVie (ZIMV) Q3 2024 Earnings Call Transcript
ZimVie Inc. Reports Improved Q3 Financial Performance
See More Headlines

ZIMV Stock Analysis - Frequently Asked Questions

ZimVie's stock was trading at $17.75 at the beginning of 2024. Since then, ZIMV stock has decreased by 20.9% and is now trading at $14.04.
View the best growth stocks for 2024 here
.

ZimVie Inc. (NASDAQ:ZIMV) released its quarterly earnings data on Thursday, August, 1st. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by $0.04. The company had revenue of $116.81 million for the quarter. ZimVie had a negative net margin of 77.31% and a positive trailing twelve-month return on equity of 2.90%.

Top institutional investors of ZimVie include Rice Hall James & Associates LLC (0.63%), Principal Financial Group Inc. (0.06%), SG Americas Securities LLC (0.03%) and Belvedere Trading LLC. Insiders that own company stock include Camber Capital Management Lp, Vafa Jamali and Richard Heppenstall.
View institutional ownership trends
.

Shares of ZIMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that ZimVie investors own include Chevron (CVX), Comcast (CMCSA), Bristol-Myers Squibb (BMY), McKesson (MCK), Charles Schwab (SCHW), Edwards Lifesciences (EW) and Yum! Brands (YUM).

Company Calendar

Last Earnings
8/01/2024
Today
11/02/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
2/26/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:ZIMV
Fax
N/A
Employees
2,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$18.33
High Stock Price Target
$23.00
Low Stock Price Target
$16.00
Potential Upside/Downside
+30.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$-393,280,000.00
Pretax Margin
-8.39%

Debt

Sales & Book Value

Annual Sales
$457.43 million
Cash Flow
$4.91 per share
Book Value
$14.73 per share

Miscellaneous

Free Float
26,742,000
Market Cap
$387.50 million
Optionable
Optionable
Beta
2.14
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (NASDAQ:ZIMV) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners